Avitar, Inc.
AVTI
Rank in Stocks
#35247
Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and... Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts.
Share Price
$0.00001
Last synced: 2026-11-20
Market Cap
$8.69
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Avitar, Inc. (AVTI)
Category
Healthcare
EPS for Avitar, Inc. (AVTI)
EPS as of December 2007 TTM: $-1.60
According to Avitar, Inc.'s latest financial reports, its current EPS (TTM) is $-1.60. At the end of 2007 the company had an EPS of $-0.11, an increase over its 2006 EPS of $-0.76.
EPS history for Avitar, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.60 | 1,354.55% |
| 2007 | $-0.11 | -85.53% |
| 2006 | $-0.76 | -8.43% |
| 2005 | $-0.83 | -40.29% |
| 2004 | $-1.39 | -72.80% |
| 2003 | $-5.11 | 1.39% |
| 2002 | $-5.04 | -47.39% |
| 2001 | $-9.58 | -7.53% |
| 2000 | $-10.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.45 | -628.13% |
IE
|
|
| $0.21 | -113.02% |
CN
|
|
| $15.05 | -1,040.43% |
CH
|
|
| $4.29 | -368.01% |
CH
|
|
| $0.13 | -107.87% |
CN
|
Questions about Avitar, Inc.'s earnings per share (EPS)
What is Avitar, Inc.'s earnings per share (EPS)?
Avitar, Inc.'s earnings per share (EPS) over the last twelve months is $-1.60, as of Dec 2007.
What was Avitar, Inc.'s earnings per share (EPS) in 2007?
In 2007, Avitar, Inc.'s earnings per share (EPS) was $-0.11, compared with $-0.76 in 2006.
How has Avitar, Inc.'s earnings per share (EPS) changed since 2002?
From 2002 to 2007, Avitar, Inc.'s earnings per share (EPS) was highest in 2007 ($-0.11) and lowest in 2003 ($-5.11).
How does Avitar, Inc.'s earnings per share (EPS) compare with similar companies?
Avitar, Inc.'s earnings per share (EPS) ($-1.60) is lower than that of all 5 similar companies listed above. The highest among them is Ypsomed Holding AG, with $15.05.